TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  Benzinga

20% Earnings Growth Potential For DexCom, Analyst Cites Buying Opportunity

Benzinga Logo Benzinga By Vandana Singh
20% Earnings Growth Potential For DexCom, Analyst Cites Buying Opportunity

DexCom reported strong Q3 2025 financial results with 22% year-over-year revenue growth, beating analyst estimates. The company raised fiscal 2025 sales guidance and expects continued growth, with William Blair maintaining a positive outlook despite recent stock price weakness.

Insights
DXCM   positive

Strong quarterly performance with 22% revenue growth, raised fiscal guidance, near-record patient additions, and analyst expectations of 20% earnings growth in 2026